#02 Workshop with Fabio Pammoli (Science & industry lunch 2)


26 Jan 2007


From 2005 until 2009, CROSSTALKS ran a bottom-up and interdisciplinary project “The Future of Medication in a Patient-centered Health Care”, a series of conferences and workshops to develop constructive dialogues between all the partners in the health care sector.

Crucial in this project was the collaborative partnership and sharing of knowledge between academics, industry, physicians, pharmacists, patients, sick funds and insurances, health and social care organizations and policymakers.


Friday, JANUARY 26 | 2007

Patents and Patients

9.30 - Welcome and coffee
10.00 - Lecture by Fabio Pammolli
10.40 - First round of comments and remarks by the discussants: Christophe Renondin* (France), Patrick Van Krunkelsven* (VLD, member of Parliament, Belgium), and Marc Noppen* (CEO, AZ-VUB)
11.15 - Coffee refill & open discussion with all the participants
12.45 - Apero + lunch

Bios / Slides

[BIO] Fabio Pammolli is Professor of Economics and Management at the University of Florence. He is the Director of European Pharmaceutical Regulation and Innovation Systems at the University of Siena. Professor Pammolli earned his degree in Economics from the University of Pisa and completed his graduate studies at the Sant'Anna School of Advanced Studies. He taught at the Richard M. Goodwin Faculty of Economics, University of Siena. Since 2001, he has been full Professor of Economics and Management at the University of Florence. Professor Pammolli is the founder and director of the European Pharmaceutical Regulation and Innovation Systems (EPRIS) and of the Economic Analysis of Competitiveness and Market Regulation (CERM). He is also the founder of Advanced Technology Assessment Inc. (A.T.A.) Professor Pammolli is a member of the Italian Health Ministry, Treasury Ministry and Industry Ministry committees. He is also a member of the Scientific Committee of the Italian National Institutes of Health. Professor Pammolli has served as advisor on competitiveness issues to the G-10 Group and the European Commission between 2002 and 2003. He is the President of the Siena Life Sciences and author of several publications on the economics of innovation and applied industrial organization. His publications have appeared, amongst others, in: the International Journal of Industrial Organization, Management Science, Physica-A, Revue d’Economie Industrielle, Research Policy and Small Business Economics.

[BIO] Jean-Christophe Renondin is general partner of CDC Entreprises Innovation in Paris, a health care venture fund which he joined in 2005. He is Board member of ZEALAND Pharma in Denmark since 2006. Mr. Renondin holds a Medical Degree from Paris specialising in Medical Biology (clinical pharmacology) as well as an MBA from Dartmouth University in New Hampshire. Within the past years, Mr. Renondin has held positions as managing director at MDS Capital, USA, vice-president of Sofinov (Societe Financiere d'Innovation), a subsidiary of The Caisse de Depot et Placement du Quebec, general manager in the Pharmaceutical Group Servier, and an associate in JP Morgan Bank.

[BIO] Patrik Vankrunkelsven, physician (Phd at KULeuven), is Professor in Medicine and a politician. Vankrunkelsven has been mayor of Laakdal since 1994. He was president of the Volksunie from 1998 until 2000, but eventually went to the VLD where he is now senator. He is politically engaged in many working groups and commissions, amongst which the Commission for Ethics (which he chairs) and the Working Group for Ethics. Keeping health care affordable and accessible is the great challenge for him.

[BIO] Marc Noppen, MD, PhD is CEO of Vrije Universiteit Brussels’ University Hospital, AZ-VUB, located in Jette. He is also Head of the Interventional Pulmonology Clinic and Professor at the Faculty of Medicine and Pharmacy at the Vrije Universiteit Brussel. He is internationally renowned in his field, has won various prizes and has important publications to his name. Since 2004, he has been Associate Editor of two renowned medical journals 'Respiration' and 'Journal of Bronchoscopy'. He serves as visiting professor at the Universities of Montréal ( Notre-Dame ), Lille ( CHRU ) and Boston ( Harvard ).


On January 26th Fabio Pammolli was the keynote speaker at the CROSSTALKS workshop “Patents and Patients”. Pammolli is an internationally renowned health economist and reported his latest study results for the European Commission. These deal with the current status of industry structure and dynamics worldwide in pharmaceuticals. In recent years, Europe’s pharmaceutical sector has come under considerable pressure. The pharma industry faces the erosion of Europe’s ancient business paradigms while being reshaped by the new laws of a globally expanding biotech and pharma industry. Pammolli elaborated on current practices and future challenges, which will undeniably affect society’s governing ideas on innovation, the protection of intellectual property, human resource management and the division of labor. Impact will likewise affect social mobility, within the framework of Europe’s commercial, administrative and religious barriers, and the need to guarantee global affordable access to health care.

Open this document 


This project could be realized due to unconditional grants by

Astra Zeneca Foundation
Janssen Pharmaceutica